Methicillin-resistant staphylococcus aureus (MRSA) mediated infection is the toughest challenge a physician face in hospitals and general community. This article will provide a brief introduction to few new drugs that are being used to treat MRSA and some other gram-negative resistant infection for some time. MRSA infection was initially found in patients those are hospitalized due to surgery or long-term illness.
Gradually, MRSA spread beyond hospital acquired infection (HA-MRSA) to the community associated MRSA (CA-MRSA). MRSA infections can be severe if they enter the bloodstream, heart, lungs or other organs. The drugs used for treating MRSA were as follows: Trimethoprim/sulfamethoxazole: Best choice for initial therapy Not effective against group A streptococc Liquid formulation Clindamycin Beneficial for treating illness with PVL and exotoxins Important to test for inducible…
